A retrospective study analysing clinical and economic outcomes associated with the initiation of intravenous (IV) belimumab for the treatment of systemic lupus erythematosus
Latest Information Update: 06 Sep 2023
At a glance
- Drugs Belimumab (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- 16 Jul 2021 New trial record
- 06 Jul 2021 Results published in the Clinical Therapeutics